COSMO Pharmaceuticals N.V. Financial Overview
COSMO Pharmaceuticals N.V.'s market cap is currently CHF1.61B. The company's EPS TTM is CHF-0.11758173588000001; its P/E ratio is 29.43; and it has a dividend yield of 1.99%. COSMO Pharmaceuticals N.V. is scheduled to report earnings on July 23, 2025, and the estimated EPS forecast is CHF0.19. See an overview of income statement, balance sheet, and cash flow financials.
